Australia Markets open in 3 hrs 14 mins

Encompass Health Corporation (EHC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
52.37+0.61 (+1.18%)
At close: 04:00PM EDT
52.08 -0.29 (-0.55%)
After hours: 05:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 364.90
52-week low 342.19
50-day moving average 358.46
200-day moving average 353.44

Share statistics

Avg vol (3-month) 3859.81k
Avg vol (10-day) 3862.46k
Shares outstanding 599.79M
Implied shares outstanding 6N/A
Float 897.28M
% held by insiders 12.02%
% held by institutions 1102.88%
Shares short (30 Jan 2023) 42.27M
Short ratio (30 Jan 2023) 43.49
Short % of float (30 Jan 2023) 42.97%
Short % of shares outstanding (30 Jan 2023) 42.28%
Shares short (prior month 29 Dec 2022) 42.52M

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 40.99%
Trailing annual dividend rate 31.12
Trailing annual dividend yield 32.16%
5-year average dividend yield 41.63
Payout ratio 433.59%
Dividend date 316 Apr 2023
Ex-dividend date 429 Dec 2022
Last split factor 21:5
Last split date 325 Oct 2006

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 6.23%
Operating margin (ttm)14.49%

Management effectiveness

Return on assets (ttm)6.30%
Return on equity (ttm)16.46%

Income statement

Revenue (ttm)4.35B
Revenue per share (ttm)43.84
Quarterly revenue growth (yoy)-13.80%
Gross profit (ttm)1.75B
Net income avi to common (ttm)257.1M
Diluted EPS (ttm)3.05
Quarterly earnings growth (yoy)-2.40%

Balance sheet

Total cash (mrq)21.8M
Total cash per share (mrq)0.22
Total debt (mrq)2.99B
Total debt/equity (mrq)160.71
Current ratio (mrq)1.25
Book value per share (mrq)16.72

Cash flow statement

Operating cash flow (ttm)705.8M
Levered free cash flow (ttm)-18.04M